Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System PR Newswire - Mon Mar 30, 3:15PM CDT

VASCADE MVP XL now approved for larger sheaths used in market-leading PFA and LAAC technologies

HAE : 56.36 (+2.60%)
WERN
3 Small-Cap Stocks That Fall Short StockStory - Sun Mar 22, 11:32PM CDT

3 Small-Cap Stocks That Fall Short

WERN : 29.41 (+2.69%)
HHH : 63.26 (+1.38%)
HAE : 56.36 (+2.60%)
HAE
2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges StockStory - Thu Mar 12, 11:38PM CDT

2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges

ZTS : 118.21 (+1.62%)
HAE : 56.36 (+2.60%)
ELV : 292.75 (+2.80%)
HAE
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q4 Earnings: Haemonetics (NYSE:HAE) Vs The Rest Of The Pack StockStory - Thu Mar 5, 9:35PM CST

A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q4 Earnings: Haemonetics (NYSE:HAE) Vs The Rest Of The Pack

HAE : 56.36 (+2.60%)
HAE
3 Reasons HAE is Risky and 1 Stock to Buy Instead StockStory - Tue Mar 3, 10:04PM CST

3 Reasons HAE is Risky and 1 Stock to Buy Instead

HAE : 56.36 (+2.60%)
GPC
3 Profitable Stocks with Open Questions StockStory - Sun Mar 1, 10:46PM CST

3 Profitable Stocks with Open Questions

ASGN : 38.71 (+1.23%)
GPC : 105.75 (+1.34%)
HAE : 56.36 (+2.60%)
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology PR Newswire - Mon Feb 23, 3:15PM CST

BOSTON , Feb. 23, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today...

HAE : 56.36 (+2.60%)
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference PR Newswire - Fri Feb 20, 3:05PM CST

BOSTON , Feb. 20, 2026 /PRNewswire/ --  Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James...

HAE : 56.36 (+2.60%)
HAE
5 Revealing Analyst Questions From Haemonetics’s Q4 Earnings Call StockStory - Wed Feb 11, 11:34PM CST

5 Revealing Analyst Questions From Haemonetics’s Q4 Earnings Call

HAE : 56.36 (+2.60%)
HAE
HAE Q4 Deep Dive: Plasma Momentum and Hospital Weakness Shape Mixed Results StockStory - Thu Feb 5, 11:34PM CST

HAE Q4 Deep Dive: Plasma Momentum and Hospital Weakness Shape Mixed Results

HAE : 56.36 (+2.60%)

Barchart Exclusives

This Dividend King Is Down 26%. When Will It Bounce Back? Barchart - 37 minutes ago
Abbott Laboratories is down 26% from its 52-week high due to a soft quarter. With 54 consecutive years of dividend hikes and guidance calling for mid-single-digit organic sales growth plus 10% EPS expansion, the Dividend King seems discounted, but the question is, can it rebound? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.